SYNJARDY 5/850MG TABS 60’S

Synjardy is a prescription medication that combines two active ingredients: empagliflozin and metformin. It is primarily used to manage type 2 diabetes in adults. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion in urine. Metformin, on the other hand, is a biguanide that improves insulin sensitivity, decreases hepatic glucose production, and enhances glucose uptake by tissues.

Synjardy is typically prescribed to improve glycemic control in conjunction with diet and exercise. It may be used alone or in combination with other diabetes medications. Additionally, it has been shown to have cardiovascular benefits in patients with type 2 diabetes and established cardiovascular disease. Patients should be monitored for potential side effects, including urinary tract infections and gastrointestinal issues.